Novartis Announces FDA Approval of Xolair[R] omalizumab for Chronic Idiopathic Urticaria CIU, a Form of Chronic Hives.
In: Pharma Business Week, 2014-04-07, S. 94
Zeitungsartikel
Zugriff:
Titel: |
Novartis Announces FDA Approval of Xolair[R] omalizumab for Chronic Idiopathic Urticaria CIU, a Form of Chronic Hives.
|
---|---|
Zeitschrift: | Pharma Business Week, 2014-04-07, S. 94 |
Veröffentlichung: | 2014 |
Medientyp: | Zeitungsartikel |
ISSN: | 1543-6675 (print) |
Sonstiges: |
|